Clinical trials sponsored by Hopital Foch

Phase breakdown

Conditions studied

Recruiting trials led by Hopital Foch

• Benefit of GnRH Agonist Before Frozen Embryo Transfer in Patients With Endometriosis and/or Adenomyosis
  NCT04356664 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 36 Years · Sex: Female · 1 location
• DOVIPA, a Study Evaluating Efficacy and Safety of DOstarlimab and VItamin D3 With mFOLFIRINOX in PAncreatic Cancer
  NCT06757244 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 5 locations
• Treatment of Chronic Pelvic Pain Due to Endometriosis by Transcutaneous Auricular Vagus Nerve Stimulation
  NCT04177511 · Phase: Not applicable (e.g. observational or device study) · Ages: 15 Years and older · Sex: Female · 1 location

Common questions

How many trials is Hopital Foch recruiting for?

Hopital Foch is the lead sponsor of 3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.